Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
FTO-IN-1 TFA
Cat. No.:
OB0425LY-121
Appearance:
Solid
Purity:
98.06%
Identity:
Confirmed by LC-MS.
Size:
Add to basket
Product Overview
Description:
FTO-IN-1 TFA is a novel small molecule inhibitor targeting FTO in the regulation of fat mass and metabolism.
Synonyms:
2797619-81-7; 2-[2,6-Dichloro-4-(3,5-dimethyl-1H-pyrazol-4-yl)anilino]-N-hydroxybenzamide;2,2,2-trifluoroacetic acid
CAS No.:
2797619-81-7
Compound CID:
162642722
Formula:
C20H17Cl2F3N4O4
Formula Weight:
505.27
Specification
Target:
Fat mass and obesity-associated protein (FTO)
Pathway:
Metabolic enzyme/Protease
Solubility:
DMSO
Storage:
Storage at 4°C.
Applications:
FTO-IN-1 TFA can be used to study the mechanisms of obesity and metabolic-related diseases, as well as to develop new therapies for obesity and related metabolic disorders.
